215 related articles for article (PubMed ID: 20596614)
1. Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade.
Barresi V; Ieni A; Bolignano D; Magno C; Buemi M; Barresi G
Oncol Rep; 2010 Aug; 24(2):305-10. PubMed ID: 20596614
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Gelatinase Associated Lipocalin is an Independent Predictor of Poor Prognosis in Cases of Papillary Renal Cell Carcinoma.
Zhang M; Zhao X; Deng Y; Tang B; Sun Q; Zhang Q; Chen W; Yao D; Yang J; Cao L; Guo H
J Urol; 2015 Sep; 194(3):647-52. PubMed ID: 25916675
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.
Bolignano D; Donato V; Lacquaniti A; Fazio MR; Bono C; Coppolino G; Buemi M
Cancer Lett; 2010 Feb; 288(1):10-6. PubMed ID: 19540040
[TBL] [Abstract][Full Text] [Related]
4. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
Barresi V; Leni A; Tuccari G; Barresi G
Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
[TBL] [Abstract][Full Text] [Related]
6. Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma.
Shinriki S; Jono H; Ueda M; Obayashi K; Nakamura T; Ota K; Ota T; Sueyoshi T; Guo J; Hayashi M; Hiraki A; Nakayama H; Yamashita S; Shinohara M; Ando Y
Histopathology; 2014 Feb; 64(3):356-64. PubMed ID: 24118080
[TBL] [Abstract][Full Text] [Related]
7. [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Perrin C; Patard JJ; Jouan F; Collet N; Théoleyre S; Edeline J; Zerrouki S; Laguerre B; Bellaud-Roturaud MA; Rioux-Leclercq N; Vigneau C
Prog Urol; 2011 Nov; 21(12):851-8. PubMed ID: 22035911
[TBL] [Abstract][Full Text] [Related]
8. NGAL immunohistochemical expression in brain primary and metastatic tumors.
Barresi V; Tuccari G; Barresi G
Clin Neuropathol; 2010; 29(5):317-22. PubMed ID: 20860895
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
Lim R; Ahmed N; Borregaard N; Riley C; Wafai R; Thompson EW; Quinn MA; Rice GE
Int J Cancer; 2007 Jun; 120(11):2426-34. PubMed ID: 17294443
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma.
Du ZP; Lv Z; Wu BL; Wu ZY; Shen JH; Wu JY; Xu XE; Huang Q; Shen J; Chen HB; Li EM; Xu LY
J Clin Pathol; 2011 Jan; 64(1):69-74. PubMed ID: 21109701
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Wang Z; Zhang X; Niu Y; Shen Z; Shen J; Wu X; Li E
J Clin Pathol; 2007 May; 60(5):555-61. PubMed ID: 17412867
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation.
Hiromoto T; Noguchi K; Yamamura M; Zushi Y; Segawa E; Takaoka K; Moridera K; Kishimoto H; Urade M
Oncol Rep; 2011 Dec; 26(6):1415-21. PubMed ID: 21874256
[TBL] [Abstract][Full Text] [Related]
15. Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.
Shalabi A; Abassi Z; Awad H; Halachmi S; Moskovitz B; Kluger Y; Nativ O
World J Urol; 2013 Dec; 31(6):1541-5. PubMed ID: 23430218
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?
Barresi V; Di Gregorio C; Reggiani-Bonetti L; Ieni A; Ponz-De Leon M; Barresi G
Hum Pathol; 2011 Nov; 42(11):1720-6. PubMed ID: 21420718
[TBL] [Abstract][Full Text] [Related]
17. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.
Candido S; Maestro R; Polesel J; Catania A; Maira F; Signorelli SS; McCubrey JA; Libra M
Oncotarget; 2014 Mar; 5(6):1576-94. PubMed ID: 24742531
[TBL] [Abstract][Full Text] [Related]
18. Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
McLean MH; Thomson AJ; Murray GI; Fyfe N; Hold GL; El-Omar EM
Br J Cancer; 2013 Jun; 108(12):2537-41. PubMed ID: 23736029
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation.
Malyszko J; Malyszko JS; Koc-Zorawska E; Kozminski P; Mysliwiec M
Kidney Blood Press Res; 2009; 32(6):464-9. PubMed ID: 20068352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
